Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

21 Dec 2022 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release today titled ‘Glenmark is the first company to launch in India a Triple FDC of Teneligliptin + Pioglitazone + Metformin for Adults with Type 2 Diabetes & High Insulin Resistance’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..